Has Stephen Dunay, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,758 in general payments to Stephen Dunay, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Dunay, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Dunay, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Dunay, MD

Interventional Pain Medicine · Totowa, NJNPI 1336487834

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Abbott at 34.2% of the total. 2025 is the largest year on record at $2,899, 3.5 times the $832 reported in 2021.

$5,758in general payments, 2019–2025

Across 32 payments — averaging $179.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
Medtronic$2K
Masimo Corporation$930
Eko Health, Inc.$599
BD$436
SPR Therapeutics, Inc$71
plus $25 from 1 others

What the payments were for

Consulting fees$1,33823%
Speaking & faculty fees$2284%
Travel & lodging$2,84449%
Food & beverage$94916%
Other$3997%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	10	$1,969
Medtronic	14	$1,727
Masimo Corporation	1	$930
Eko Health, Inc.	2	$599
BD	2	$436
SPR Therapeutics, Inc	2	$71
CSL Behring	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,758 in reported general payments places this provider in the 65th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$13,556

Medicare patients

Services billed

105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	18	$94

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Totowa

Youssef JosephsonWest Deptford$496K
Ali ValimahomedHolmdel$415K
Saurabh DangEdgewater$157K
Gabriele JasperBrick$114K
Matthew LippChatham$67K
Didier DemesminSomerset$33K
Steve AydinFranklin Lakes$22K
Kieran SlevinHainesport$21K
John CoccaroToms River$17K
Dinash YanamadulaLawrenceville$16K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →